| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/26/2000 | EP0974058A2 20 human secreted proteins |
| 01/26/2000 | EP0973934A1 Transgenically produced non-secreted proteins |
| 01/26/2000 | EP0973892A2 28 human secreted proteins |
| 01/26/2000 | EP0973879A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 01/26/2000 | EP0973803A1 Peptides useful for reducing symptoms of toxic shock syndrome |
| 01/26/2000 | EP0973802A1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses |
| 01/26/2000 | EP0973799A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/26/2000 | EP0973797A1 Peptide compositions which induce immune tolerance and methods of use |
| 01/26/2000 | EP0973767A1 Indazoles of cyclic ureas useful as hiv protease inhibitors |
| 01/26/2000 | EP0973755A1 Asymmetric synthesis of benzoxazinones via new intermediates |
| 01/26/2000 | EP0973750A1 Substituted benzimidazoles and their use for treating retroviral infection |
| 01/26/2000 | EP0973732A2 Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivatives, process for their preparation and their use as pharmaceuticals |
| 01/26/2000 | EP0973548A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
| 01/26/2000 | EP0973518A1 Semi-synthetic studies toward didemnin analogues |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973502A1 Lipophilic binary systems for the administration of lipophilic compounds |
| 01/26/2000 | EP0973501A2 Aqueous suspension for nasal administration of loteprednol |
| 01/26/2000 | EP0763016B1 Compositions and methods for treating mast-cell mediated conditions |
| 01/26/2000 | EP0587735B1 T cell receptor peptides as therapeutics for immune-related disease |
| 01/26/2000 | CN1242802A Notch protein and their ligands |
| 01/25/2000 | US6018019 Immunogenic synthetic peptides which are useful alone or in conjugates in vaccines against hemophilus influenza infection |
| 01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
| 01/25/2000 | US6017916 Nonpeptide endothelin antagonists I |
| 01/25/2000 | US6017909 Salts of azelastine having improved solubility effective at treating psoriasis and providing a cytoprotective effect |
| 01/25/2000 | US6017889 Metalloproteinase inhibitors |
| 01/25/2000 | US6017879 Template associated NPY Y2-receptor agonists |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/25/2000 | US6017735 A fusion polypeptide having a herpes virus virion protein and a second protein selected from cell cycle control, suicide protein, antigenic sequences, immunomodulating or therapeutic protein; antiproliferative/anticarcinogenic agents |
| 01/25/2000 | US6017729 Receptor activator of NF-κB |
| 01/25/2000 | US6017544 Isolating stress protein-peptide complex from tumor cells previously removed from a mammal and administering the isolated stress protein-peptide complex along with a cytokine to the mammal in order to stimulate an immune response |
| 01/25/2000 | US6017540 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
| 01/25/2000 | US6017539 Multimeric hybrid genes encoding corresponding chimeric protein comprise gene sequence coding for antigenic region of protein from first pathogen linked to gene sequence coding for antigenic region of protein from second pathogen |
| 01/25/2000 | US6017537 Immunological adjuvants comprised of the n-formyl methionyl peptide fmlp used as an adjuvant to provide for an immune response to suboptimal doses of recombinant antigens |
| 01/25/2000 | US6017532 Porphyromonas gingivalis arginine-specific proteinase |
| 01/25/2000 | US6017526 Germanium yeast human diet nutritional supplement |
| 01/20/2000 | WO2000003036A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | WO2000003029A2 Chimaeric adenoviruses |
| 01/20/2000 | WO2000003016A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | WO2000002923A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 01/20/2000 | WO2000002913A1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use |
| 01/20/2000 | WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 01/20/2000 | WO2000002879A1 Lk6-a derivatives |
| 01/20/2000 | WO2000002877A2 New pharmaceutically active compounds |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002858A1 Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors |
| 01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
| 01/20/2000 | WO2000002583A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 01/20/2000 | WO2000002581A1 Antigenic peptides derived from telomerase |
| 01/20/2000 | WO2000002563A1 Steroid-containing cataplasms and process for producing the same |
| 01/20/2000 | WO2000002560A1 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE ORAL COMPOSITIONS |
| 01/20/2000 | WO2000002558A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | WO2000002520A2 T-lymphocyte exchange |
| 01/20/2000 | WO1999059633A8 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 01/20/2000 | WO1999059627A3 Verotoxin b subunit for immunization |
| 01/20/2000 | WO1999059541A3 Cyclosporin preparations |
| 01/20/2000 | WO1999051742A3 Dadd, death activator death domain protein |
| 01/20/2000 | WO1999049037A3 Protein phosphatase-related molecules |
| 01/20/2000 | WO1999040115A9 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT |
| 01/20/2000 | CA2748996A1 Antigenic peptides derived from telomerase |
| 01/20/2000 | CA2377178A1 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2]pyridine oral compositions |
| 01/20/2000 | CA2337261A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | CA2336884A1 Lk6-a derivatives |
| 01/20/2000 | CA2335382A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | CA2335090A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | CA2333898A1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use |
| 01/19/2000 | EP0972780A1 Il-6 antagonist peptides |
| 01/19/2000 | EP0972524A1 Lymphocyte activation inhibitors |
| 01/19/2000 | EP0972523A2 Method and compositions for inducing immunity to viruses |
| 01/19/2000 | EP0972518A2 Exchange of T lymphocytes |
| 01/19/2000 | EP0972054A1 Enhancement of immune response using targeting molecules |
| 01/19/2000 | EP0972044A1 Chemokine beta-6 |
| 01/19/2000 | EP0972040A1 Human gtp binding protein |
| 01/19/2000 | EP0972034A1 Bi- or multifunctional molecules based on a dendroaspin scaffold |
| 01/19/2000 | EP0972032A2 Peptides for the treatment of systemic lupus erythematosus |
| 01/19/2000 | EP0972026A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971955A1 Secreted proteins |
| 01/19/2000 | EP0971954A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971950A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971945A1 Uronium salt conjugate vaccines |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971901A1 Phthalazinones |
| 01/19/2000 | EP0971895A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |
| 01/19/2000 | EP0971892A1 Novel pyridine derivatives and pharmaceutical compositions containing them |
| 01/19/2000 | EP0971736A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 01/19/2000 | EP0971730A2 Assay for ligands to tyrosine kinase receptors |
| 01/19/2000 | EP0971715A1 Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread |
| 01/19/2000 | EP0971588A1 Novel cannabinoid receptor modulators |
| 01/19/2000 | EP0971587A1 Quinoline leukotriene antagonists |
| 01/19/2000 | EP0728144B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 01/19/2000 | CN1241999A Vitamin D3 derivatives |
| 01/19/2000 | CN1241906A Adjuvant for transcutaneous immunization |
| 01/19/2000 | CN1048495C Tetrahydropyran derivatives, its producing process and their medical composition containing them |
| 01/18/2000 | US6015913 Heating cocoa beans to loosen shell without roasting nib, winnowing nibs from shells, screw pressing nibs to produce cocoa butter and partially defatted cocoa solids |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015884 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/18/2000 | US6015883 Amino acid sequence of purified chemokine polypeptide; treatment of immune deficiency diseases, autoimmune diseases, allergies or asthma; anticarcinogenic/antiinflammatory/ antiarthritic agents |
| 01/18/2000 | US6015831 Thiophene nitrone compounds |
| 01/18/2000 | US6015712 Antisense modulation of FADD expression |